Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney. Shire US Manufacturing Inc.: LIALDA is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Lialda (mesalamine).
Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the inssrt of remission of UC. The content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites.
E-mail to a Friend
Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda.
Click OK if you are a health care professional. Shire does not control the content of non-Shire Web sites, and this link does not constitute an endorsement by Shire of the site’s content. Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda.
E-mail this page or Web site to a friend or loved one by filling out the form below. Following Your Prescribed Treatment Plan.
All other intellectual property rights packagd reserved. Please see Full Prescribing Information for Lialda mesalamine. The information contained in this section of the site is intended for US health care professionals only.